Abstract：Objective: To compare the value of Gd-EOB-DTPA enhanced MRI with hepatospecific phase with that of Gd-EOB-DTPA enhanced MRI without hepatospecific phase and contrast-enhanced MDCT in diagnosis of focal liver lesions(FLL). Methods: Thirty-eight patients with 55 FLLs underwent MDCT and Gd-EOB-DTPA enhanced MRI. FLLs were verified based on pathological or follow-up results. CT and MR images were independently analyzed by four radiologists on an ordinal 6-point-scale. Results: Compared to MDCT and MRI without hepatospecific phase, more FLLs were correctly classified into benign and malignant entities by each of the four radiologists on MRI with hepatospecific phase. MDCT achieved sensitivity of 51.6%, specificity of 56.5%, and diagnostic accuracy of 53.6%; MRI without hepatospecific phase achieved sensitivity of 68.8%, specificity of 59.8%, and diagnostic accuracy of 65.0%; MRI with hepatospecific pahse achieved higher sensitivity (89.1%), specificity(78.3%) and accuracy(84.5%) compared to MDCT and MRI without hepatospecific phase(P<0.05). Conclusion: Gd-EOB-DTPA enhanced MRI with hepatospecific phase provides significantly higher diagnostic efficacy compared to MDCT and Gd-EOB-DTPA enhanced MRI without hepatospecific phase in diagnosis of FLLs.
佟 晶，卑贵光，李玉泽，徐 冉，刘 宁，程志亮. 钆塞酸二钠增强MR与增强CT在肝脏局灶性病变诊断中的对比研究[J]. 中国临床医学影像杂志, 2017, 28(9): 642-646.
TONG Jing, BEI Gui-guang, LI Yu-ze, XU Ran, LIU Ning, CHENG Zhi-liang. Comparative study between Gd-EOB-DTPA enhanced MRI and triple phase multidetector CT in#br#
diagnosis of focal liver lesions. JOURNAL OF CHINA MEDICAL IMAGING, 2017, 28(9): 642-646.
[1]Meloni MF, Andreano A, Franza E, et al. Contrast enhanced ultrasound: Should it play a role in immediate evaluation of liver tumors following thermal ablation?[J]. Eur J Radiol, 2012, 81(8): e897-902.
[2]Furlan A, Marin D, Cabassa P, et al. Enhancement pattern of small hepatocellular carcinoma(HCC) at contrast-enhanced US(CEUS), MDCT, and MRI: Intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases(AASLD) guidelines[J]. Eur J Radiol, 2012, 81(9): 2099-2105.
[3]Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver[J]. Radiology, 2001, 218(1): 27-38.
[4]Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system[J]. Radiology, 1992, 183(1): 59-64.
[5]B?觟ttcher J, Hansch A, Pfeil A, et al. Detection and classification of different liver lesions: Comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation[J]. Eur J Radiol, 2013, 82(11): 1860-1869.
[6]李小庆，周智鹏，何松青，等. 磁共振成像对比剂Gd-EOB-DTPA动态增强对肝脏局灶性病变的临床价值[J]. 中华肝胆外科杂志，2013，19（11）：815-819.
[7]Baek CK, Choi JY, Kim KA, et al. Hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT[J]. Clin Radiol, 2012, 67(2): 148-156.
[8]Kim SH, Lee J, Kim MJ, et al. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma[J]. AJR, 2009, 192(6): 1675-1681.
[9]Akai H, Kiryu S, Matsuda I, et al. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: Comparison with triple phase 64 detector row helical CT[J]. Eur J Radiol, 2011, 80(2): 310-315.
[10]Holalkere NS, Sahani DV, Blake MA, et al. Characterization of small liver lesions: added role of MR after MDCT[J]. J Comput Assist Tomogr, 2006, 30(4): 591-596.
[11]Hammerstingl R, Huppertz A, Breuer J, et al. Diagnostic efficacy of gadoxetic acid(Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions[J]. Eur Radiol, 2008, 18(3): 457-467.
[12]Baron RL, Oliver JH, Dodd GD, et al. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT[J]. Radiology, 1996, 199(2): 505-511.
[13]Jang HJ, Lim JH, Lee SJ, et al. Hepatocellular carcinoma: are combined CT during arterial portography and CT hepatic arteriography in addition to triple-phase helical CT all necessary for preoperative evaluation?[J]. Radiology, 2000, 215(2): 373-380.
[14]Kang BK, Lim JH, Kim SH, et al. Preoperative depiction of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT[J]. Radiology, 2003, 226(1): 79-85.
[15]Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT—initial observations[J]. Radiology, 2005, 234(2): 468-478.
[16]丁莺，曾蒙苏. 普美显在肝硬化结节多步癌变及肝细胞癌早期诊断中的应用[J]. 临床肝胆病杂志，2013，29（10）：736-739.
[17]Kim SH, Jeong WK, Kim Y, et al. Hepatocellular carcinoma composed of two different histologic types: imaging features on gadoxetic acid enhanced liver MRI[J]. Clin Mol Hepatol, 2013, 19(1): 92-96．
[18]Golfieri R, Renzulli M, Lucidi V, et a1. Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small(≤2 cm) HCC in cirrhosis[J]. Eur Radiol, 2011, 21(6): 1233-1242.
[19]Inoue T, Kudo M, Komuta M, et al. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT[J]. J Gastroenterol, 2012, 47(9): 1036-1047.
[20]中华医学会放射学分会腹部学组. 肝胆特异性MRI对比剂钆塞酸二钠临床应用专家共识[J]. 中华放射学杂志，2016，50（9）：641-646.
[21]Kitao A, Matsui O, Yoneda N, et al. Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images[J]. Radiology, 2012, 265(3): 780-789.
2017, Vol. 28 
